68

Shenzhen Lifotronic Technology Co LtdSHG 688389 Stock Report

Last reporting period 30 Sep, 2023

Updated 16 Oct, 2024

Last price

Market cap $B

1.18

Small

Exchange

XSHG - Shanghai Stock Exchange

688389.SS Stock Analysis

68

Attractive

Based on Eyestock quantitative analysis, 688389.SS`s fundamental data and valuation indicate an investment grade of Attractive at the current time.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

106/100

High score

Upside

To determine whether the current price is a reasonable to buy a stock, we compare it to our estimate of fair value. The more undervalued a stock is, the higher the upside.

139.4 %

Greatly undervalued

Market cap $B

1.18

Dividend yield

Shares outstanding

422.2 B

Shenzhen Lifotronic Technology Co Ltd is a China-based company mainly engaged in the research, development, manufacturing and marketing of medical devices. The Company focuses on the development and technological innovation of treatment and rehabilitation equipment, in vitro diagnostic equipment and supporting detection reagents. The Company's products mainly include wound and skin treatment products, perioperative and intensive care products, pain and rehabilitation treatment products and in vitro diagnostic products. The Company mainly conducts its businesses in domestic and overseas markets.

View Section: Eyestock Rating